Key Insights

Highlights

Success Rate

86% trial completion

Treatment Research

13 treatments under study, led by Dexmecamylamine Hcl

Research Leaders

11 sponsors active, led by Atacama Therapeutics

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

85.7%

-0.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (3)
Phase 2 (5)

Trial Status

Completed6
Terminated1
Unknown1
Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (9)

Research Network

Common Treatments

  • Dexmecamylamine Hcl2
  • Bupivacaine Lidocaine Dexamethasone1
  • Glycopyrronium 24 Medicated Cloth1
  • Nearinfrared Imaging Thoracoscopy1
  • Polymer Skin Barrier1

Active Sponsors

  • Atacama Therapeutics2
  • Fayoum University1
  • Tmaer Youssef Mohamed1
  • Miller Biosciences LLC1
  • Dryox Health S.L.1

Top Investigators

Related Conditions

  • Hyperhidrosis2
  • Skin Diseases1
  • Sweat Gland Diseases1
  • Severe Primary Hand Hyperhidrosis1

Activity Timeline